Cibc World Markets Corp Invests $482,000 in DaVita Inc. (NYSE:DVA)

Cibc World Markets Corp purchased a new position in DaVita Inc. (NYSE:DVA – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,461 shares of the company’s stock, valued at approximately $482,000.

A number of other institutional investors also recently made changes to their positions in the business. First Trust Advisors LP grew its holdings in shares of DaVita by 443.7% during the 4th quarter. First Trust Advisors LP now owns 146,530 shares of the company’s stock valued at $10,941,000 after purchasing an additional 119,579 shares during the last quarter. Sowell Financial Services LLC bought a new position in shares of DaVita during the 4th quarter valued at $918,000. Royal London Asset Management Ltd. grew its holdings in shares of DaVita by 1.6% during the 4th quarter. Royal London Asset Management Ltd. now owns 19,372 shares of the company’s stock valued at $1,446,000 after purchasing an additional 307 shares during the last quarter. Citigroup Inc. grew its holdings in shares of DaVita by 32.4% during the 4th quarter. Citigroup Inc. now owns 88,874 shares of the company’s stock valued at $6,636,000 after purchasing an additional 21,750 shares during the last quarter. Finally, Prudential PLC bought a new position in shares of DaVita during the 4th quarter valued at $505,000. Hedge funds and other institutional investors own 86.52% of the company’s stock.

Insider Activity at DaVita

In related news, Director Charles Berg sold 735 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $81.78, for a total transaction of $60,108.30. Following the completion of the sale, the director now directly owns 17,164 shares in the company, valued at $1,403,671.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other DaVita news, Director Charles Berg sold 735 shares of the company’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $81.78, for a total value of $60,108.30. Following the completion of the transaction, the director now directly owns 17,164 shares in the company, valued at $1,403,671.92. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Javier Rodriguez sold 16,916 shares of the company’s stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $99.44, for a total transaction of $1,682,127.04. Following the completion of the transaction, the chief executive officer now owns 315,622 shares of the company’s stock, valued at $31,385,451.68. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,668 shares of company stock worth $3,889,765. 1.00% of the stock is owned by company insiders.

DaVita Trading Down 0.6 %

Shares of DVA opened at $100.33 on Monday. The company has a current ratio of 1.18, a quick ratio of 1.14 and a debt-to-equity ratio of 8.25. The firm’s 50-day moving average price is $85.34 and its 200-day moving average price is $79.92. DaVita Inc. has a 1-year low of $65.28 and a 1-year high of $103.00. The firm has a market capitalization of $9.10 billion, a price-to-earnings ratio of 18.51, a PEG ratio of 1.02 and a beta of 0.93.

DaVita (NYSE:DVA – Get Rating) last released its quarterly earnings data on Monday, May 8th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.50. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.84 billion. DaVita had a net margin of 4.40% and a return on equity of 72.08%. The firm’s quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.61 earnings per share. Sell-side analysts anticipate that DaVita Inc. will post 6.72 EPS for the current year.

Analyst Ratings Changes

DVA has been the topic of several recent research reports. TheStreet raised shares of DaVita from a “c” rating to a “b-” rating in a report on Monday, May 8th. Sanford C. Bernstein raised their price target on shares of DaVita from $88.00 to $100.00 in a report on Monday, May 15th. Cowen raised their price target on shares of DaVita from $76.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, February 23rd. Deutsche Bank Aktiengesellschaft raised their price target on shares of DaVita from $85.00 to $113.00 in a report on Tuesday, May 9th. Finally, StockNews.com started coverage on shares of DaVita in a report on Thursday. They issued a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, DaVita presently has an average rating of “Hold” and a consensus price target of $96.88.

DaVita Profile

(Get Rating)

DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.